Amgen, Inc. (AMGN)
353.95
+5.52
(+1.58%)
USD |
NASDAQ |
Mar 25, 16:00
352.00
-1.95
(-0.55%)
After-Hours: 20:00
Amgen Cash from Investing (Quarterly) : -693.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -1.232B |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Eli Lilly & Co. | -2.802B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.603B |
| Cash from Financing (Quarterly) | -1.226B |
| Free Cash Flow | 8.10B |
| Free Cash Flow Per Share (Quarterly) | 1.770 |
| Free Cash Flow to Equity (Quarterly) | 113.00M |
| Free Cash Flow to Firm (Quarterly) | 1.536B |
| Free Cash Flow Yield | 4.22% |